A Pilot Open-Label Clinical Trial of CPI-613 in Patients With Advanced Bile Duct Cancers

Trial Profile

A Pilot Open-Label Clinical Trial of CPI-613 in Patients With Advanced Bile Duct Cancers

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 28 Aug 2017

At a glance

  • Drugs CPI 613 (Primary)
  • Indications Cholangiocarcinoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Aug 2017 Planned End Date changed from 1 May 2017 to 1 Feb 2018.
    • 14 Aug 2017 Planned primary completion date changed from 1 May 2017 to 1 Feb 2018.
    • 06 Jun 2017 Results (n=14) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top